Emerald Advisers’s ANI Pharmaceuticals ANIP Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q3 | $115K | Hold |
|
|||||
|
2025
Q2 | $82K | Buy |
|
|||||
|
2025
Q1 | $16.3K | Hold |
|
|||||
|
2024
Q4 | $13.5K | Hold |
|
|||||
|
2024
Q3 | $14.6K | Hold |
|
|||||
|
2024
Q2 | $15.5K | Hold |
|
|||||
|
2024
Q1 | $16.9K | Hold |
|
|||||
|
2023
Q4 | $13.5K | Sell |
|
|||||
|
2023
Q3 | $10.1M | Buy |
|
|||||
|
2023
Q2 | $9.38M | Sell |
|
|||||
|
2023
Q1 | $14.8M | Sell |
|
|||||
|
2022
Q4 | $17.8M | Sell |
|
|||||
|
2022
Q3 | $14.7M | Buy |
|
|||||
|
2022
Q2 | $13.5M | Buy |
|
|||||
|
2022
Q1 | $9.95M | Buy |
|
|||||
|
2021
Q4 | $3.82M | Buy |
|
|||||
|
2014
Q4 | – | Sell |
|
|||||
|
2014
Q3 | $3.27M | Buy |
|
|||||
|
2014
Q2 | $3.9M | Buy |
|
|||||
|
2014
Q1 | $2.26M | Buy |
|